NCT02211261
Who may be able to join
Who might be able to join this trial:
- Men and women with Type 2 Diabetes who are not able to become pregnant
- People who have been taking a stable dose of the diabetes medication metformin (at least 1500mg per day for one part of the study, or at least 1000mg per day for another part) for at least 30 days before the screening appointment
- People whose blood sugar control, measured by a test called HbA1c, falls within a certain range at screening — between 7–10% for one part of the study, or 6.5–10% for another part
- People whose blood test shows a certain level of a substance called C-peptide, which indicates the body is still producing some insulin (confirm with trial site for exact values that apply to you)
Who may not be able to join:
- People who have been diagnosed with Type 1 Diabetes
- People who have diabetes-related complications that have caused serious damage to major organs
- People who have a history of long-term inflammation of the pancreas, or who are considered at high risk of developing it
- People whose high blood pressure is not well managed or controlled
- People who have previously had a heart attack, stroke, or any related heart or brain procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants With All-Causality and Treatment Related Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events; Number of Participants With Dose Limiting or Intolerable Adverse Events; Number of Participants With Positive Anti-drug Antibody (ADA) Result
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.